Pathfinder Cell Therapy (Pathfinder Cell Therapy) Interest Expense : $-0.31 Mil (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pathfinder Cell Therapy's interest expense for the three months ended in Sep. 2015 was $ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pathfinder Cell Therapy's Operating Income for the three months ended in Sep. 2015 was $ -0.21 Mil. Pathfinder Cell Therapy's Interest Expense for the three months ended in Sep. 2015 was $ -0.08 Mil. Pathfinder Cell Therapy did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pathfinder Cell Therapy Interest Expense Historical Data

The historical data trend for Pathfinder Cell Therapy's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Interest Expense Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.11

-0.10

-0.20

-0.28

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Interest Expense	Get a 7-Day Free Trial															-0.07	-0.08	-0.07	-0.08	-0.08

Pathfinder Cell Therapy Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

Pathfinder Cell Therapy (OTCPK:PFND) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pathfinder Cell Therapy's Interest Expense for the three months ended in Sep. 2015 was $-0.08 Mil. Its Operating Income for the three months ended in Sep. 2015 was $-0.21 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2015 was $0.00 Mil.

Pathfinder Cell Therapy's Interest Coverage for the quarter that ended in Sep. 2015 is calculated as

Pathfinder Cell Therapy did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines